the public should be informed of the findings for example the likelihood of a patient in a lowincome country receiving one or more medicines for secondary prevention of cardiovascular disease is only per cent compared to per cent in an uppermiddleincome country the high price of some noncommunicable disease medicines together with the growing burden of noncommunicable diseases could make offering universal health coverage in some countries less effective less sustainable or otherwise financially unviable